In pediatric midline gliomas and astrocytomas with K27M mutations, MYC/PVT1 also exhibited copy number amplification and patients with this subtype experienced a poorer prognosis.40, 41. This evidence concerns the gene MYC and astrocytoma (excluding glioblastoma).